Crispr Therapeutics Ag (CRSP)

Operating Margin

-3971.53%

TTM · Period ending:

CRSP logo

CRSP Operating Margin

Latest reported-3971.53%
CRSP TTM Operating Margin (-10416.60% → -3971.53%)
High-resolution chart · PNG

CRSP operating margin history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Crispr Therapeutics Ag Operating Margin — Trailing twelve months (TTM)
Period endingOperating Margin
-3,971.5278%
-13,408.2866%
-16,191.396%
-1,270.1004%
-1,221.1596%
-1,282.7223%
-1,273.9672%
-164.8592%
-176.4368%
-110.4006%
-60.1454%
-249.2041%
-278.4474%
-560.2306%
-154,394.7248%
-5,156.5609%
-4,672.5081%
34.1612%
40.8839%
45.6624%
49.7174%
-51,752.8796%
-49,295.5494%
-304.6481%
-1.428%
7.4553%
16.1401%
-4.453%
-14,959.6677%
-8,613.6103%
-5,087.8041%
-319.0779%
-233.8151%
-178.8081%
-157.6896%
-825.4357%
-805.3645%
-1,044.8113%
-1,319.3261%
-1,792.8269%
-3,068.3794%
-4,653.527%
-10,416.5992%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.